USPTO serial 79289025
Serial No. 79289025
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 14, 2021
- Examiner
- HOLTZ, ALLISON
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with Serial No. 79289025?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*
Plus Government fees of $650
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Zhi Dong
Zhi Dong Hamre, Schumann, Mueller & Larson, P.C.45 South Seventh Street, Suite 2700Minneapolis, MN 55402UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Nutritive substances for microorganisms for medical purposes; diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposes; reagent paper for medical or veterinary purposes; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for the treatment of colorectal diseases and colorectal cancer; biological preparations for medical purposes for the treatment of colorectal diseases and colorectal cancer; bacteriological preparations for medical and veterinary use; chemical preparations for pharmaceutical purposes for the treatment of colorectal diseases and colorectal cancer; enzyme preparations for medical purposes | ACTIVE | — |
| 010 | Diagnostic apparatus for medical purposes, namely, diagnostic apparatus for the detection and screening of tumors, and medical diagnostic apparatus for testing tumor cells and DNA; blood testing apparatus; hemocytometers; sphygmomanometers; apparatus for use in medical analysis, namely, apparatus for analyzing blood, body fluid and excrement, and medical diagnostic apparatus for analyzing and measuring tumor cells in the blood, body fluid and excrement samples; testing apparatus for medical purposes, namely, testing apparatus for blood, body fluid and excrement, medical diagnostic apparatus for testing DNA and RNA samples, and tumor cells testing apparatus for medical use; medical apparatus and instruments, namely, medical apparatus and instruments for monitoring characteristic of blood, body fluid and excrement, medical apparatus and instruments for treating cancers, medical apparatus and instruments for preventing or reversing cancers, and medical apparatus and instruments for measuring and displaying tumor cells in the blood, body fluid and excrement samples; bottles for taking samples for medical use, namely, medical sterile specimen containers, sold empty; respirators for artificial respiration; apparatus for artificial respiration | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Helixgen(Guangzhou)Co.,Ltd.
- Other trademarks owned by Helixgen(Guangzhou)Co.,Ltd.
- Other trademarks owned by Helixgen(Guangzhou)Co.,Ltd.
- Other trademarks in Class 005
- Other trademarks in Class 010
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 21, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 25, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 24, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 14, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 14, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 25, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Sep 28, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 28, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 22, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 22, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Sep 8, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 22, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 20, 2021 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Feb 20, 2021 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Feb 20, 2021 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Feb 18, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 17, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 17, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 27, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 6, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 31, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 4, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 3, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 3, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 14, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 10, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 9, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |